5LMB
HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-1 |
Synchrotron site | ESRF |
Beamline | ID23-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2009-03-06 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 1.0724 |
Spacegroup name | P 1 |
Unit cell lengths | 39.849, 41.780, 86.991 |
Unit cell angles | 99.81, 90.41, 100.03 |
Refinement procedure
Resolution | 20.000 - 1.950 |
R-factor | 0.1777 |
Rwork | 0.175 |
R-free | 0.22810 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | In-house coordinates |
RMSD bond length | 0.006 |
RMSD bond angle | 1.190 |
Data scaling software | SCALA (3.3.1) |
Refinement software | REFMAC (5.8.0073) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 42.835 | 42.835 | 2.060 |
High resolution limit [Å] | 1.950 | 6.170 | 1.950 |
Rmerge | 0.055 | 0.029 | 0.400 |
Number of reflections | 37810 | ||
<I/σ(I)> | 8.5 | 18.5 | 1.8 |
Completeness [%] | 95.3 | 94.6 | 92.8 |
Redundancy | 1.9 | 1.9 | 1.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.8 | 293 | PEG1500, HEPES, TACSIMATE, GLYCEROL |